Citizens News Report

  • About/Contact
  • Staff
  • Privacy Policy

  • Business
  • U.S.
  • Entertainment
  • Health
  • Technology
  • World
  • Sports
  • Politics

Biogen Profit Drops, But Beats Forecast

January 27, 2016 By Troi Freelan Leave a Comment

Biogen Profit Drops, But Beats Forecast

Biogen (NASDAQ: BIIB) reported profit for the fourth quarter that declined but easily topped expectations as its sales of treatments for multiple sclerosis surged. Sales of its treatment Tecfidera jumped by 8.4% to over $993 million as sales of other treatments it has for multiple sclerosis dropped. The profit at the biotechnology company fell by […]

Filed Under: Business, Health Tagged With: Biogen Idec, MS Drugs, Multiple Sclerosis

LOKSYS INTERNATIONAL SEALS 5 YEAR DEAL WITH COSTA RICAN GOVERNMENT

Computhink Receives Place in CFO Tech Outlook’s Top 10 Financial Control and Automation Solution Providers 2019

RECENT FEDERAL AND STATE GOVERNMENT ATTEMPTS TO COMPEL PRODUCTION OF PRESIDENT TRUMP’S INDIVIDUAL FEDERAL AND STATE TAX RETURNS RUN AFOUL OF OUR CONSTITUTIONAL LAW.

Federal Government Seizure of President Trump’s New York State Individual Tax Returns is Most Likely a Violation of the Fourth Amendment

Arizona’s Misting Pioneers Export Products and Services to Mexico

People Edgy about use of Voice for Healthcare

Witstock continues its 2019 growth plans with the appointment of Graham Peacop as Non-Executive Chairman

Newport Hospitality Group Selected to Manage Candlewood Suites Houston/Pasadena Texas

Copyright © 2021 · Citizens News Report